Vaxxinity

VAXX57

Penny Stock

$0.06arrow_drop_up200.00%$0.04

Penny Stock

VAXX57

$0.06

arrow_drop_up200.00%$0.04

Penny Stock

Performance History

Key Stats
Open	$0.06
Prev. Close	$0.02
EPS	-0.45
Dividend	Non-Dividend
Next Earnings Date	-
Dividend Yield %	-
Market Cap	$253.57K
PE Ratio	-

	LOW	HIGH
Day Range	0.06	0.06
52 Week Range	0.00	1.33

Ratios

Revenue	-



EBITDA Margin %	-

EPS	-0.45

Score Breakdown

Welcome to Stocklytics

Don't miss out on the opportunity to stay ahead in the ever-changing world of finance.

Analyst Forecast

Period: Next 12 Months

•

Analyst Ratings

•

About Vaxxinity (VAXX)

The Vaxxinity, Inc. (VAXX) is a globally renowned biopharmaceutical company specializing in the development and manufacturing of advanced vaccines. With a strong focus on innovation and cutting-edge research, Vaxxinity has emerged as a key player in the healthcare industry. The company's stock price history reflects its remarkable growth and success, with consistent upward trends over the years. Investors have witnessed substantial returns on their investments as the VAXX stock value has soared to new heights.

Vaxxinity's commitment to delivering life-saving vaccines is evident in its extensive product portfolio. The company's quote on the stock exchange stands as a testament to its industry-leading position. The VAXX stock is in high demand among both institutional and individual investors, thanks to its impressive track record and promising future prospects. As a pioneer in vaccine development, Vaxxinity has revolutionized preventive medicine and continues to make significant strides in combating an array of diseases.

Websitecall_made

Sector: Healthcare
Industry: Biotechnology
CEO: Ms. Mei Mei Hu J.D.
Headquarters: Merritt Island
Employees: 87
Exchange: NASDAQ

Keep an eye on Vaxxinity

Adding the right stocks to your watchlist can provide valuable insights and opportunities for strategic decision-making.

Frequently Asked Questions

help

What is Vaxxinity's (VAXX) price per share?

The current price per share for Vaxxinity (VAXX) is $0.06. The stock has seen a price change of $0.04 recently, indicating a 0% change. This reflects the stock's recent market performance and investor sentiment.

help

What is the 52-week high and low for Vaxxinity (VAXX)?

For Vaxxinity (VAXX), the 52-week high is $1.33, which is 2.12K% from the current price. The 52-week low is $0, the current price is 5.9K% above the 52-week low. This gives investors an insight into the stock's volatility and price range over the past year.

help

Is Vaxxinity (VAXX) a growth stock?

Vaxxinity (VAXX) has shown an average price growth of -1.93% over the past three years. It has received a score of 0 out of 100 based on the Stocklytics formula. The interpretation of this score in terms of classifying Vaxxinity as a growth stock may vary, considering it is one of many factors investors might evaluate, including market trends, financial performance, and future prospects of the company.

help

What is Vaxxinity (VAXX) stock price performance year to date (YTD)?

As of the latest data, Vaxxinity (VAXX) has a year-to-date price change of -92.9%. Over the past month, the stock has experienced a price change of 20%. Over the last three months, the change has been -84.5%. Over the past six months, the figure is -86.36%.

help

Is Vaxxinity (VAXX) a profitable company?

Vaxxinity (VAXX) has a net income of -$56.93M, which represents the company's total earnings after all expenses have been deducted from revenues. The gross margin of indicates the percentage of revenue that exceeds the cost of goods sold, and the operating margin of 0% reflects the percentage of revenue remaining after covering variable production costs, highlighting the efficiency of the company's core operations. Total revenue stands at , with a revenue growth rate of 100%, providing insight into the company's sales performance and growth. Operating income is noted at -$58.28K. Furthermore, the EBITDA is -$56.05M.

help

What is the market capitalization of Vaxxinity (VAXX)?

Vaxxinity (VAXX) has a market capitalization of $253.57K. The average daily trading volume is 5.19K, indicating the stock's liquidity and investor engagement.